Natco Pharma Scores Big with Generic Cancer Drug Approval!

Yo, Natco Pharma just hit the jackpot, gettin’ the thumbs up from the US health peeps for their generic cancer fighter, Erdafitinib. This magic pill comes in 3, 4, and 5 mg doses, ready to help folks tackle that tricky urothelial carcinoma. And check it, their stock is cruisin’ at Rs 851.45, feelin’ that market love, fo’ shizzle!